LIVINGSTON, New Jersey--Milestone Scientific, a leader in advanced injection technologies, has announced that it has granted China National Medicines Corporation, d/b/a Sinopharm, exclusive distribution and marketing rights of the STA Single Tooth Anesthesia System in China.
Traded on the Shanghai Stock Exchange, Sinopharm is China's largest domestic manufacturer, distributor and marketer of pharmaceuticals and importer of medical devices, and the country's largest domestic distributor of dental anesthetic carpules to the Chinese dental industry.
The deal paves the way for Milestone's Computer-Controlled Local Anesthetic Delivery technologies to reach progressive oral health practitioners in China through Sinopharm's extensive medical and dental distribution network.
According to Global Industry Analysts, Inc., one of the world's largest market research publishers, "Rapid growth in living standards has induced greater realization about the quality of medical and dental services in countries such as India and China. Consequently, these countries are exhibiting soaring demand for modern and sophisticated technology and equipment in the dental market." Market research firm Freedonia also notes that "demand for dental products in China is expected to climb 11% per year through 2012 to 21.5 billion yuan ($3.15 billion U.S. dollars), driven by the increasing number of Chinese who are using dental products to improve their appearance and the growing popularity of professional dental care."
Leonard Osser, chairman and interim CEO of Milestone, stated, "An important factor of Milestone's long term success is teaming with the right distribution partners who are capable of promoting rapid market penetration for our advanced injection technologies in key geographic regions around the world. Considering that China represents one of the most significant growth markets for the STA System, our efforts to identify an ideal partner in that global region has been especially pronounced. As a result, we are very proud to team with Sinopharm, one of China's noted healthcare leaders, as our exclusive supplier of the STA System and related ancillary handpieces in China and look forward to working closely with them to help establish our technologies as the gold standard for dental injections in the country."
The STA System is a computer-controlled, pressure-sensitive injection system, that provides dentists with audible and visual signals as to in-tissue pressure and needle location. Milestone's latest achievement in C-CLAD makes the injection process comfortable for dentists and patients and allows for the painless delivery of local anesthetic.
Marketed worldwide by Milestone's growing global distributor network to dental practitioners for the painless administration of dental injections, the STA System is capable of predictably and comfortably administering "Single Tooth Anesthesia" into the periodontal intraligamentary space.
Established in 1999 by China National Pharmaceutical Group Corporation, China's largest pharmaceutical group, China National Medicine Corporation Ltd.'s (Sinopharm) core businesses are investment, import and export, and domestic distribution in pharmaceutical and relevant sections, including pharmaceutical R&D, manufacturing, distribution, consultation, bonded warehousing and other value-added services.
Among these services are overseas pharmaceutical projects and domestic wholesale of pharmaceuticals, medical instruments and equipments. Sinopharm keeps the country's medicine reserve and plays an important role in disaster and emergency relief and disease and plague prevention.
To read more about Milestone Scientific, go to Milestone Scientific.
To comment on this subject, go to PennWell Dental Community site.